Summary
Federal Circuit affirms plaintiff’s damages theory that relies on sufficiently comparable license to calculate reasonable royalty; court says there is an assumption that apportionment was built into negotiations for comparable license, obviating need for further apportionment in instant case.
Vectura v. GlaxoSmithKline LLC
PDF, Size: 193 KB
See Also
Sufficiently Comparable License Obviates Further Apportionment for Reasonable Royalty
Federal Circuit affirms plaintiff’s damages theory that relies on sufficiently comparable license to calculate reasonable royalty; court says there is an assumption that apportionment was built into negotiations for comparable license, obviating need for further apportionment in instant case.